Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-23-011338

SVP, Business Development acquired 32,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Birznieks Gunther SVP, Business Development 2023-02-16 Grant or award +32,700 222,757 D
Derivatives
Birznieks Gunther SVP, Business Development 2023-02-16 Grant or award · Stock Option (Right to Buy) +77,500 77,500 D
Loading xslF345X03/doc4.xml…